2nd Quarter - Report
NVG, LLC for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent Quality Improvement Act of 2013 (S. 866, H.R. 2766), Patent Abuse Reduction Act of 2013 (S. 1013, H.R. 2639); The Innovation Act (HR 3309); Patent Transparency and Improvements Act of 2013 (S. 1720); General issues related to intellectual property and potential changes to the patent system
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.